Trial Profile
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase 0
Latest Information Update: 02 Sep 2021
Price :
$35
*
At a glance
- Drugs Selonsertib (Primary) ; Prednisolone
- Indications Alcoholic hepatitis
- Focus Therapeutic Use
- 27 Mar 2017 New trial record